Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents i…

2024 ESMO Annual Meeting Insights Hub

P. Garrido

Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated …

Total Health

M. Armstrong

How Are Outpatient irAEs Managed at Mass General

Cleveland Clinic Taussig Cancer Institute

K. Rubin

Managing Cardiotoxicities in TKI Therapy for CLL: Atrial Fibrillatio…

Avirup Guha

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

Debra Richardson

How the Experts Manage: ADC-Associated Toxicities in NSCLC

MI&T Congressi

N. Leighl

Managing Cardiotoxicities in BTKi Treatment for CLL: Atrial Fibrilla…

Lydia Scarfò

WCLC 2024 Insights: Management of Radiation Toxicities in The Era of…

Insights from 2024 WCLC

P. Lee